(2017). Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: Current evidence and future perspectives. Metalloproteinases In Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Metalloproteinases and Their Inhibitors as Therapeutic Targets for Multiple Sclerosis: Current Evidence and Future Perspectives."
Metalloproteinases In Medicine 2017.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Metalloproteinases and Their Inhibitors as Therapeutic Targets for Multiple Sclerosis: Current Evidence and Future Perspectives."
Metalloproteinases In Medicine, 2017.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.